How has the transradial access products market evolved, and where is it heading next?
The transradial access products market size has grown rapidly in recent years. It will grow from $2.20 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, rising geriatric population, rising number of cases of cardiovascular diseases, rise in the prevalence of lifestyle disorders and cardiovascular diseases, increasing awareness about the benefits of radial access.
The transradial access products market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to growing demand for minimally invasive surgeries, increasing number of cases of cancer, increasing preference for vascular access devices, increasing heart-related disease and obesity, increasing prevalence of the Chronic disease . Major trends in the forecast period include advancements in technology for the treatment, adoption of transradial access techniques, adoption of transradial access techniques and devices in clinical practice, new technology penetration, peripheral intervention technologies.
Get Your Free Sample of The Global Transradial Access Products Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21303&type=smp
What are the key drivers behind the rapid expansion of the transradial access products market?
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the transradial access products market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The increasing prevalence of cardiovascular diseases is attributed to factors such as sedentary lifestyles, unhealthy diets, obesity, smoking, excessive alcohol consumption, and aging populations, leading to higher incidences of hypertension, diabetes, and other risk factors. Transradial access products improve cardiovascular disease treatment by enabling minimally invasive catheterization procedures, reducing complications, enhancing patient comfort, and accelerating recovery times. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, doctor-certified deaths due to coronary heart disease (CHD) rose to 14,900 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the transradial access products market.
Increase In Obesity Cases Driving The Growth Of The Market
The increase in obesity cases is expected to propel the growth of the transradial access products market going forward. Obesity refers to a medical condition characterized by excessive body fat accumulation that increases the risk of health problems such as heart disease, diabetes, and hypertension. The increase in obesity cases is attributed to factors such as sedentary lifestyles, high-calorie diets, increased consumption of processed foods, and reduced physical activity. Transradial access products help obesity cases by enabling minimally invasive vascular procedures through the radial artery, reducing complications, improving patient comfort, and supporting better clinical outcomes for individuals with higher BMI. For instance, in September 2023, according to the Centers for Disease Control and Prevention, a US-based government administration, in 2022, updated population data shows that 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. Therefore, the increase in obesity cases is driving the growth of the transradial access products market.
What is the segmentation for the transradial access products market?
The transradial access products market covered in this report is segmented –
1) By Product: Catheter, Guidewire, Sheath, Other Products
2) By Application: Diagnostic And Interventional, Drug Administration, Blood Transfusion, Other Applications
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Catheter: Diagnostic Catheters, Guiding Catheters, Balloon Catheters
2) By Guidewire: Hydrophilic Guidewires, Nitinol Guidewires, Stainless Steel Guidewires
3) By Sheath: Introducer Sheaths, Radial Sheath Sets, Hydrophilic-Coated Sheaths
4) By Other Products: Hemostatic Devices, Compression Bands, Vascular Closure Devices
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/transradial-access-products-global-market-report
Who are the most influential companies in the transradial access products market?
Major companies operating in the transradial access products market are Johnson & Johnson, Abbott Vascular, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Teleflex Incorporated, Cook Medical, Biotronik SE & Co., Smiths Medical, Merit Medical Systems Inc., Penumbra Inc., Angiodynamics Inc., Oscor Inc., Asahi Intecc Co. Ltd., Nipro Medical Corporation, Vascular Solutions Inc., TherOx Inc.
What are the most influential trends expected to drive the transradial access products market forward?
Major companies operating in the transradial access products market are focusing on developing innovative products such as peripheral support catheter to enhance procedural efficiency and improve patient outcomes. A peripheral support catheter refers to a specialized catheter designed to provide additional support and stability during complex peripheral vascular interventions, such as crossing chronic total occlusions or navigating tortuous arteries. For instance, in December 2024, Terumo Interventional Systems (TIS), a division of Terumo Corporation, a US-based medical technology, launched Its R2P NaviCross Peripheral Support Catheter. This provides a wide range of interventional products, including catheters, guidewires, sheaths, and other devices used in cardiovascular and peripheral procedures. The R2P NaviCross Peripheral Support Catheter is designed to support guidewires and improve navigation during complex peripheral vascular procedures, helping to cross difficult lesions and access challenging areas in peripheral arteries.
What are the major regional insights for the transradial access products market, and which region holds the top position?
North America was the largest region in the transradial access products market in 2024. The regions covered in the transradial access products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Transradial Access Products Market Report 2025 Offer?
The transradial access products market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Transradial access products are medical devices used to gain access to the circulatory system through the radial artery in the wrist, commonly for procedures such as coronary angiography and angioplasty. Transradial access is utilized in medical procedures, primarily in cardiology, by gaining access to the circulatory system through the radial artery in the wrist.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21303
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
